United States· US:50742-263_8f0d4438-1ba8-419c-864f-b95cb0b006ef
Probenecid and Colchicine
A colchicine and probenecid product containing probenecid; colchicine, registered in United States by Ingenus Pharmaceuticals, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PROBENECID; COLCHICINE
- Manufacturer
- Ingenus Pharmaceuticals, LLC
- Country
- United States (US)
- ATC code
- M04AC51
- ATC class
- Colchicine and probenecid
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc115074226301100 TABLET in 1 BOTTLE (50742-263-01)
- ndc1150742-263-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under M04AC51
Colchicine and probenecid, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e37c4d47-05b4-4114-b510-2053259400c8 GET /v1/drugs/e37c4d47-05b4-4114-b510-2053259400c8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "500; .5",
"substance": "PROBENECID; COLCHICINE",
"productndc": "50742-263",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA040618",
"marketing_category": "ANDA"
}See everything about colchicine and probenecid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.